On the public citation graph

The Economic Burden of Schizophrenia in the United States in 2002

https://doi.org/10.4088/jcp.v66n0906
0 signed · 566 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3290147openalex-extracted
The Sperm-Banking Crisis and the Need for a New Means of Legal Redress or New Tricks for Old Torts
inferred← citeshttps://doi.org/10.2139/ssrn.3333787openalex-extracted
the Sperminator As a Public Nuisance: Redressing Wrongful Life and Birth Claims in New Ways (AKA New Tricks for Old Torts)
inferred← citeshttps://doi.org/10.1001/archgenpsychiatry.2011.129openalex-snapshot
Randomized Trial to Evaluate the Efficacy of Cognitive Therapy for Low-Functioning Patients With Schizophrenia
inferred← citeshttps://doi.org/10.1001/jama.2013.8804openalex-snapshot
Early Detection and Intervention in Schizophrenia
inferred← citeshttps://doi.org/10.1001/jamapsychiatry.2013.1909openalex-snapshot
Prediction of Functional Outcome in Individuals at Clinical High Risk for Psychosis
inferred← citeshttps://doi.org/10.1001/jamapsychiatry.2020.1596openalex-snapshot
Association of End Point Definition and Randomized Clinical Trial Duration in Clinical Trials of Schizophrenia Medications
inferred← citeshttps://doi.org/10.1001/journalofethics.2016.18.6.msoc1-1606openalex-snapshot
Psychosis Risk: What Is It and How Should We Talk About It?
inferred← citeshttps://doi.org/10.1002/14651858.cd010880openalex-snapshot
Peer support for schizophrenia
inferred← citeshttps://doi.org/10.1002/14651858.cd010880.pub2openalex-snapshot
Peer support for people with schizophrenia or other serious mental illness
inferred← citeshttps://doi.org/10.1002/9780470479216.corpsy0820openalex-snapshot
Schizophrenia
inferred← citeshttps://doi.org/10.1002/9780470479216.corpsy0822openalex-snapshot
Schizophrenia, Functional Outcomes in
inferred← citeshttps://doi.org/10.1002/9780470515167.ch65openalex-snapshot
Schizophrenia and Other Psychoses
inferred← citeshttps://doi.org/10.1002/9781118133880.hop208010openalex-snapshot
Schizophrenia Spectrum Conditions
inferred← citeshttps://doi.org/10.1002/9781118309421.ch5openalex-snapshot
Glutamatergic Synaptic Dysregulation in Schizophrenia
inferred← citeshttps://doi.org/10.1002/9781118499184.ch1openalex-snapshot
Introduction to Mindfulness and Acceptance‐based Therapies for Psychosis
inferred← citeshttps://doi.org/10.1002/9781118753378.ch48openalex-snapshot
Schizophrenia and Other Psychoses
inferred← citeshttps://doi.org/10.1002/9781118877142.ch13openalex-snapshot
Schizophrenia and Severe Mental Illness
inferred← citeshttps://doi.org/10.1002/9781394258970.ch6openalex-snapshot
Schizophrenia Spectrum and Other Psychotic Disorders
inferred← citeshttps://doi.org/10.1002/9781444327298.ch31openalex-snapshot
Societal Outcomes in Schizophrenia
inferred← citeshttps://doi.org/10.1002/9781444393552.ch7openalex-snapshot
Cognitive Enhancing Drugs
inferred← citeshttps://doi.org/10.1002/ajmg.b.32242openalex-snapshot
The genetics of functional disability in schizophrenia and bipolar illness: Methods and initial results for VA cooperative study #572
inferred← citeshttps://doi.org/10.1002/cmdc.200800074openalex-snapshot
Multi‐Receptor Binding Profile of Clozapine and Olanzapine: A Structural Study Based on the New β2 Adrenergic Receptor Template
inferred← citeshttps://doi.org/10.1002/ddr.21295openalex-snapshot
Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia
inferred← citeshttps://doi.org/10.1002/hbm.70165openalex-snapshot
The Psychosis MRI Shared Data Resource (Psy‐ ShareD )
inferred← citeshttps://doi.org/10.1002/mpr.1855openalex-snapshot
Relationship between clinical outcomes measures and personal and social performance functioning in a prospective, interventional study in schizophrenia
inferred← citeshttps://doi.org/10.1002/pds.4354openalex-snapshot
“Impact of drug‐reimbursement policies on prescribing: A case‐study of a newly marketed long‐acting injectable antipsychotic among relapsed schizophrenia patients”
inferred← citeshttps://doi.org/10.1002/phar.1634openalex-snapshot
Estimating the Impact of Adherence to and Persistence with Atypical Antipsychotic Therapy on Health Care Costs and Risk of Hospitalization
inferred← citeshttps://doi.org/10.1002/stem.762openalex-snapshot
Concise Review: The Promise of Human Induced Pluripotent Stem Cell-Based Studies of Schizophrenia
inferred← citeshttps://doi.org/10.1007/7355_2014_54openalex-snapshot
The Use of PDE10A and PDE9 Inhibitors for Treating Schizophrenia
inferred← citeshttps://doi.org/10.1007/7854_2010_56openalex-snapshot
Treatment Implications of the Schizophrenia Prodrome
inferred← citeshttps://doi.org/10.1007/978-1-4614-1870-2_1openalex-snapshot
Overview
inferred← citeshttps://doi.org/10.1007/978-1-4614-5999-6_84openalex-snapshot
Pharmacology and Primary Prevention
inferred← citeshttps://doi.org/10.1007/978-1-4614-6633-8_22openalex-snapshot
Reforming the Behavioral Health Delivery System for Adolescents: Why Is It Needed and What Is Psychology’s Role?
inferred← citeshttps://doi.org/10.1007/978-1-4899-7497-6_19openalex-snapshot
Schizophrenia
inferred← citeshttps://doi.org/10.1007/978-1-4939-1056-4_15openalex-snapshot
Evidence of Glutamatergic Dysfunction in the Pathophysiology of Schizophrenia
inferred← citeshttps://doi.org/10.1007/978-1-4939-2528-5_39openalex-snapshot
Rating Scales for Psychiatric Disorders
inferred← citeshttps://doi.org/10.1007/978-1-59745-439-1_17openalex-snapshot
Pharmacogenomics Applications in Psychiatric Disorders
inferred← citeshttps://doi.org/10.1007/978-3-030-26269-3_15openalex-snapshot
Other Neurological Disorders: Migraine, Neurosarcoidosis, Schizophrenia, Obstructive Sleep Apnea-Hypopnea Syndrome and Bipolar Disorder
inferred← citeshttps://doi.org/10.1007/978-3-030-46835-4_15openalex-snapshot
Severe Psychopathology
inferred← citeshttps://doi.org/10.1007/978-3-031-72156-4_15openalex-snapshot
Other Neurological Disorders: Migraine, Neurosarcoidosis, Schizophrenia, Obstructive Sleep Apnea-Hypopnea Syndrome and Bipolar Disorder
inferred← citeshttps://doi.org/10.1007/978-3-0346-0241-9_6openalex-snapshot
Activation of Group II Metabotropic Glutamate Receptors (mGluR2 and mGluR3) as a Novel Approach for Treatment of Schizophrenia
inferred← citeshttps://doi.org/10.1007/978-3-319-24085-5_9openalex-snapshot
Other Neurological Disorders: Migraine, Neurosarcoidosis, Schizophrenia, Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS)
inferred← citeshttps://doi.org/10.1007/978-3-319-30061-0_12openalex-snapshot
Quality of Life and Health Costs: The Feasibility of Cost-Utility Analysis in Schizophrenia
inferred← citeshttps://doi.org/10.1007/978-3-319-64786-9_26openalex-snapshot
Meeting the Needs of Rural Adults with Mental Illness and Dual Diagnoses
inferred← citeshttps://doi.org/10.1007/978-3-642-25758-2_10openalex-snapshot
Glutamatergic Synaptic Dysregulation in Schizophrenia: Therapeutic Implications
inferred← citeshttps://doi.org/10.1007/978-3-642-45257-4_1openalex-snapshot
Treatment-Refractory Schizophrenia: Definition and Assessment
inferred← citeshttps://doi.org/10.1007/978-94-007-0834-1_9openalex-snapshot
Interventions Targeting Social and Vocational Dysfunction in Individuals with a Schizophrenia Spectrum Disorder
inferred← citeshttps://doi.org/10.1007/978-94-007-5866-7_4openalex-snapshot
New Animal Models of Progressive Neurodegeneration: Tools for Developing Predictive Diagnostics and Identifying Presymptomatic Therapeutic Targets
inferred← citeshttps://doi.org/10.1007/978-94-017-8610-2_2openalex-snapshot
Measuring Anhedonia in Schizophrenia-Spectrum Disorders: A Selective Update
inferred← citeshttps://doi.org/10.1007/978-94-017-9576-0_16openalex-snapshot
Neurosurgery for the Treatment of Refractory Schizophrenia
inferred← citeshttps://doi.org/10.1007/978-981-287-080-3_271-1openalex-snapshot
Schizophrenia and Other Psychotic Disorders in Older Adults
inferred← citeshttps://doi.org/10.1007/978-981-287-082-7_271openalex-snapshot
Schizophrenia and Other Psychotic Disorders in Older Adults
inferred← citeshttps://doi.org/10.1007/bf03320712openalex-snapshot
Analisi costo-efficacia dello switch da un trattamento antipsicotico a risperidone iniettabile a rilascio prolungato in pazienti con schizofrenia
inferred← citeshttps://doi.org/10.1007/bf03320713openalex-snapshot
Analisi di costo-efficacia dello switch da un antipsicotico orale a risperidone a rilascio prolungato nel trattamento dei pazienti affetti da schizofrenia
inferred← citeshttps://doi.org/10.1007/s00103-012-1624-yopenalex-snapshot
Die Berechnung indikationsspezifischer Kosten bei GKV-Routinedatenanalysen am Beispiel von ADHS
inferred← citeshttps://doi.org/10.1007/s00103-016-2327-6openalex-snapshot
Erratum zu: Die Berechnung indikationsspezifischer Kosten bei GKV-Routinedatenanalysen am Beispiel von ADHS
inferred← citeshttps://doi.org/10.1007/s00213-012-2838-2openalex-snapshot
Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study
inferred← citeshttps://doi.org/10.1007/s00406-007-0763-xopenalex-snapshot
Patterns of mental health service utilization in a general hospital and outpatient mental health facilities
inferred← citeshttps://doi.org/10.1007/s00406-014-0541-5openalex-snapshot
Prediction and prevention of psychosis: current progress and future tasks
inferred← citeshttps://doi.org/10.1007/s00439-016-1737-8openalex-snapshot
Genetic factor common to schizophrenia and HIV infection is associated with risky sexual behavior: antagonistic vs. synergistic pleiotropic SNPs enriched for distinctly different biological functions
inferred← citeshttps://doi.org/10.1007/s00787-009-0018-7openalex-snapshot
Medication adherence for children and adolescents with first-episode psychosis following hospitalization
inferred← citeshttps://doi.org/10.1007/s00787-018-1140-1openalex-snapshot
Diagnostic efficiency of the CBCL thought problems and DSM-oriented psychotic symptoms scales for pediatric psychotic symptoms
inferred← citeshttps://doi.org/10.1007/s10198-006-0350-5openalex-snapshot
The costs of schizophrenia in Spain
inferred← citeshttps://doi.org/10.1007/s10198-020-01200-0openalex-snapshot
The excess economic burden of mental disorders: findings from a cross-sectional prevalence survey in Austria
inferred← citeshttps://doi.org/10.1007/s10488-012-0444-6openalex-snapshot
Making the Case for IPS Supported Employment
inferred← citeshttps://doi.org/10.1007/s10488-013-0503-7openalex-snapshot
Examining the Relationship Between Adjunctive Psychotherapy Use and Antipsychotic Persistence and Hospitalization
inferred← citeshttps://doi.org/10.1007/s10597-013-9622-6openalex-snapshot
Burdens and Psychological Health of Family Caregivers of People with Schizophrenia in Two Chinese Metropolitan Cities: Hong Kong and Guangzhou
inferred← citeshttps://doi.org/10.1007/s10597-013-9638-yopenalex-snapshot
Impact of Oral Antipsychotic Medication Adherence on Healthcare Resource Utilization Among Schizophrenia Patients with Medicare Coverage
inferred← citeshttps://doi.org/10.1007/s10597-013-9650-2openalex-snapshot
Barriers and Facilitators of a Healthy Lifestyle Among Persons with Serious and Persistent Mental Illness: Perspectives of Community Mental Health Providers
inferred← citeshttps://doi.org/10.1007/s10597-019-00411-xopenalex-snapshot
Psychiatric Risk Assessment from the Clinician’s Perspective: Lessons for the Future
inferred← citeshttps://doi.org/10.1007/s11095-010-0152-4openalex-snapshot
In Vitro–In Vivo Correlations of Scalable PLGA-Risperidone Implants for the Treatment of Schizophrenia
inferred← citeshttps://doi.org/10.1007/s11414-013-9329-zopenalex-snapshot
Healthcare Cost Reductions Associated with the Use of LAI Formulations of Antipsychotic Medications Versus Oral Among Patients with Schizophrenia
inferred← citeshttps://doi.org/10.1007/s11414-016-9515-xopenalex-snapshot
Community Health Workers: a Resource to Support Antipsychotic Medication Adherence
inferred← citeshttps://doi.org/10.1007/s11920-010-0129-3openalex-snapshot
Vocational, Social, and Cognitive Rehabilitation for Individuals Diagnosed With Schizophrenia: A Review of Recent Research and Trends
inferred← citeshttps://doi.org/10.1007/s11920-012-0271-1openalex-snapshot
Deinstitutionalization? Where Have All the People Gone?
inferred← citeshttps://doi.org/10.1007/s11920-014-0439-yopenalex-snapshot
Is Prevention a Realistic Goal for Schizophrenia?
inferred← citeshttps://doi.org/10.1007/s12325-012-0001-4openalex-snapshot
Cognitive Impairment Associated with Schizophrenia: A Review of the Humanistic Burden
inferred← citeshttps://doi.org/10.1007/s12325-017-0507-xopenalex-snapshot
Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly
inferred← citeshttps://doi.org/10.1007/s12325-018-0786-xopenalex-snapshot
Treatment Patterns, Healthcare Resource Utilization and Costs Among Schizophrenia Patients Treated with Long-Acting Injectable Versus Oral Antipsychotics
inferred← citeshttps://doi.org/10.1007/s40258-018-0408-4openalex-snapshot
Costs in the Treatment of Schizophrenia in Adults Receiving Atypical Antipsychotics: An 11-Year Cohort in Brazil
inferred← citeshttps://doi.org/10.1007/s40261-014-0202-5openalex-snapshot
Comparison of Health Services Use Associated with Ziprasidone and Olanzapine among Schizophrenia and Bipolar Disorder Patients in the USA
inferred← citeshttps://doi.org/10.1007/s40263-021-00815-yopenalex-snapshot
Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.1007/s40273-016-0444-6openalex-snapshot
The Societal Cost of Schizophrenia: A Systematic Review
inferred← citeshttps://doi.org/10.1007/s40273-022-01217-8openalex-snapshot
The Societal Cost of Schizophrenia: An Updated Systematic Review of Cost-of-Illness Studies
inferred← citeshttps://doi.org/10.1007/s40596-014-0198-4openalex-snapshot
The Cost of Inpatient Care of Schizophrenia in the Polish and Ukrainian Academic Centers—Poznan and Lviv
inferred← citeshttps://doi.org/10.1007/s40801-015-0043-4openalex-snapshot
Costs and Resource Utilization Among Medicaid Patients with Schizophrenia Treated with Paliperidone Palmitate or Oral Atypical Antipsychotics
inferred← citeshttps://doi.org/10.1007/s41669-018-0089-9openalex-snapshot
Adherence, Healthcare Resource Utilization, and Costs in Medicaid Beneficiaries with Schizophrenia Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate
inferred← citeshttps://doi.org/10.1007/s44192-023-00050-5openalex-snapshot
Beta-2 adrenergic receptor agonism alters astrocyte phagocytic activity and has potential applications to psychiatric disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-383834-6.00117-8openalex-snapshot
Schizophrenia and Affective Disorders
inferred← citeshttps://doi.org/10.1016/b978-0-12-387718-5.00011-0openalex-snapshot
Algorithm development for diagnostic biomarker assays
inferred← citeshttps://doi.org/10.1016/b978-0-12-387718-5.00012-2openalex-snapshot
Challenges of Introducing New Biomarker Products for Neuropsychiatric Disorders into the Market
inferred← citeshttps://doi.org/10.1016/b978-0-12-815012-2.00018-3openalex-snapshot
Promoting Psychosocial Functioning and Recovery in Schizophrenia Spectrum and Other Psychotic Disorders
inferred← citeshttps://doi.org/10.1016/b978-0-323-04743-2.50066-4openalex-snapshot
Chronic Mental Illness
inferred← citeshttps://doi.org/10.1016/b978-0-444-63639-3.00025-6openalex-snapshot
Mapping pathologic circuitry in schizophrenia
inferred← citeshttps://doi.org/10.1016/b978-012369429-4/50036-7openalex-snapshot
Relapse Prevention for Schizophrenia
inferred← citeshttps://doi.org/10.1016/b978-2-294-74526-3.00005-xopenalex-snapshot
COMBIMOD, un programme intégratif de réhabilitation et de remédiation cognitive pour la schizophrénie
inferred← citeshttps://doi.org/10.1016/bs.irn.2015.07.002openalex-snapshot
The Role of Nicotine in Schizophrenia
inferred← citeshttps://doi.org/10.1016/j.ajp.2013.11.011openalex-snapshot
Psychotic disorders in Asian Americans and DSM-5
inferred← citeshttps://doi.org/10.1016/j.amjsurg.2012.06.013openalex-snapshot
Breast cancer in patients with schizophrenia
inferred← citeshttps://doi.org/10.1016/j.apnu.2006.11.005openalex-snapshot
Transition to Community: A Program to Help Clients with Schizophrenia Move from Inpatient to Community Care; A Pilot Study
inferred← citeshttps://doi.org/10.1016/j.apnu.2016.01.001openalex-snapshot
Concept Analysis of Illness Engulfment in Schizophrenia
inferred← citeshttps://doi.org/10.1016/j.arth.2017.12.006openalex-snapshot
Increased Complications for Schizophrenia and Bipolar Disorder Patients Undergoing Total Joint Arthroplasty
inferred← citeshttps://doi.org/10.1016/j.bbi.2022.03.013openalex-snapshot
Machine learning based prediction and the influence of complement – Coagulation pathway proteins on clinical outcome: Results from the NEURAPRO trial
inferred← citeshttps://doi.org/10.1016/j.bbr.2009.04.010openalex-snapshot
Animal models of gene–environment interactions in schizophrenia
inferred← citeshttps://doi.org/10.1016/j.bmc.2016.11.018openalex-snapshot
Triazolopyridine ethers as potent, orally active mGlu2 positive allosteric modulators for treating schizophrenia
inferred← citeshttps://doi.org/10.1016/j.cbpra.2018.08.004openalex-snapshot
Statewide Implementation of Cognitive Behavioral Therapy for Psychosis Through a Learning Collaborative Model
inferred← citeshttps://doi.org/10.1016/j.cct.2019.04.005openalex-snapshot
Incentivizing healthy lifestyle behaviors to reduce cardiovascular risk in people with serious mental illness: An equipoise randomized controlled trial of the wellness incentives program
inferred← citeshttps://doi.org/10.1016/j.chc.2013.04.009openalex-snapshot
Community Rehabilitation and Psychosocial Interventions for Psychotic Disorders in Youth
inferred← citeshttps://doi.org/10.1016/j.clinph.2012.02.077openalex-snapshot
Do impairments in facial analysis underlie impaired social functioning in schizophrenia?
inferred← citeshttps://doi.org/10.1016/j.comppsych.2017.01.018openalex-snapshot
Feasibility and acceptability of post-hospitalization ecological momentary assessment in patients with psychotic-spectrum disorders
inferred← citeshttps://doi.org/10.1016/j.cpr.2010.03.002openalex-snapshot
Upward spirals of positive emotions counter downward spirals of negativity: Insights from the broaden-and-build theory and affective neuroscience on the treatment of emotion dysfunctions and deficits in psychopathology
inferred← citeshttps://doi.org/10.1016/j.drudis.2016.08.001openalex-snapshot
Multi-target therapeutics for neuropsychiatric and neurodegenerative disorders
inferred← citeshttps://doi.org/10.1016/j.ehrm.2011.07.005openalex-snapshot
Meeting Highlights on Psychosis and Schizophrenia: The 3rd Annual Chair Summit
inferred← citeshttps://doi.org/10.1016/j.ehrm.2012.06.003openalex-snapshot
Health Care Utilization and Costs among Medicaid-enrolled Patients with Schizophrenia Experiencing Multiple Psychiatric Relapses
inferred← citeshttps://doi.org/10.1016/j.electacta.2014.03.045openalex-snapshot
Redox cycling-based amplifying electrochemical sensor for in situ clozapine antipsychotic treatment monitoring
inferred← citeshttps://doi.org/10.1016/j.encep.2012.11.004openalex-snapshot
Le coût de la schizophrénie : revue de la littérature internationale
inferred← citeshttps://doi.org/10.1016/j.euroneuro.2017.11.020openalex-snapshot
Factors associated with direct health care costs in schizophrenia: Results from the FACE-SZ French dataset
inferred← citeshttps://doi.org/10.1016/j.euroneuro.2019.01.105openalex-snapshot
Structural changes in the hippocampus as a biomarker for cognitive improvements in neuropsychiatric disorders: A systematic review
inferred← citeshttps://doi.org/10.1016/j.eurpsy.2007.02.003openalex-snapshot
Economic consequences of alternative medication strategies in first episode non-affective psychosis
inferred← citeshttps://doi.org/10.1016/j.jad.2017.09.011openalex-snapshot
The economic burden of bipolar I disorder in the United States in 2015
inferred← citeshttps://doi.org/10.1016/j.jagp.2012.10.011openalex-snapshot
Cognitive Performance of Individuals With Schizophrenia Across Seven Decades: A Study Using the MATRICS Consensus Cognitive Battery
inferred← citeshttps://doi.org/10.1016/j.jpain.2006.01.443openalex-snapshot
Cost-Effectiveness of Duloxetine Versus Routine Treatment for U.S. Patients With Diabetic Peripheral Neuropathic Pain
inferred← citeshttps://doi.org/10.1016/j.jpeds.2007.04.007openalex-snapshot
Pediatric Research in the Era of Clinical and Translational Science Awards
inferred← citeshttps://doi.org/10.1016/j.jprot.2013.08.001openalex-snapshot
The Human Proteome Organization Chromosome 6 Consortium: Integrating chromosome-centric and biology/disease driven strategies
inferred← citeshttps://doi.org/10.1016/j.jpsychires.2026.06.033openalex-snapshot
Duration of untreated psychosis and long-term outcomes: A systematic review examining the critical window hypothesis
inferred← citeshttps://doi.org/10.1016/j.jval.2011.08.1741openalex-snapshot
Updating and Confirming an Industry-Sponsored Pharmacoeconomic Model: Comparing Two Antipsychotics in the Treatment of Schizophrenia
inferred← citeshttps://doi.org/10.1016/j.jval.2013.03.074openalex-snapshot
Burden Of Schizophrenia On Selected Comorbidities Costs
inferred← citeshttps://doi.org/10.1016/j.jval.2014.02.008openalex-snapshot
Cost-Effectiveness of Second-Generation Antipsychotics for the Treatment of Schizophrenia
inferred← citeshttps://doi.org/10.1016/j.neubiorev.2015.09.006openalex-snapshot
Cognition in at-risk mental states for psychosis
inferred← citeshttps://doi.org/10.1016/j.neubiorev.2015.09.020openalex-snapshot
Molecular regulation of dendritic spine dynamics and their potential impact on synaptic plasticity and neurological diseases
inferred← citeshttps://doi.org/10.1016/j.neures.2014.08.006openalex-snapshot
The course of neuropsychological impairment and brain structure abnormalities in psychotic disorders
inferred← citeshttps://doi.org/10.1016/j.neuropharm.2010.11.015openalex-snapshot
T-type calcium channel antagonism produces antipsychotic-like effects and reduces stimulant-induced glutamate release in the nucleus accumbens of rats
inferred← citeshttps://doi.org/10.1016/j.neuroscience.2012.04.044openalex-snapshot
Dendritic spine pathology in schizophrenia
inferred← citeshttps://doi.org/10.1016/j.neuroscience.2021.10.014openalex-snapshot
Altered Visuospatial Processing in Schizophrenia: An Event-related Potential Microstate Analysis Comparing Patients with and without Hallucinations with Healthy Controls
inferred← citeshttps://doi.org/10.1016/j.npbr.2018.05.004openalex-snapshot
Cost-effectiveness of psychotropic polypharmacy in routine schizophrenia care. Results of the ELAN prospective observational trial
inferred← citeshttps://doi.org/10.1016/j.pnpbp.2011.06.004openalex-snapshot
Effects of haloperidol on cognition in schizophrenia patients depend on baseline performance: A saccadic eye movement study
inferred← citeshttps://doi.org/10.1016/j.pnpbp.2017.11.001openalex-snapshot
Therapeutic effect of adjunctive N-acetyl cysteine (NAC) on symptoms of chronic schizophrenia: A double-blind, randomized clinical trial
inferred← citeshttps://doi.org/10.1016/j.pnpbp.2019.01.005openalex-snapshot
Dendritic spines: Revisiting the physiological role
inferred← citeshttps://doi.org/10.1016/j.pnpbp.2023.110850openalex-snapshot
Cerebral and cerebellar correlates of social cognitive impairment in schizophrenia
inferred← citeshttps://doi.org/10.1016/j.prevetmed.2014.10.009openalex-snapshot
Estimating the population attributable fraction for schizophrenia when Toxoplasma gondii is assumed absent in human populations
inferred← citeshttps://doi.org/10.1016/j.psc.2010.11.012openalex-snapshot
Prevention of the First Episode of Psychosis
inferred← citeshttps://doi.org/10.1016/j.psc.2012.06.004openalex-snapshot
Is Early Intervention for Psychosis Feasible and Effective?
inferred← citeshttps://doi.org/10.1016/j.psc.2012.06.008openalex-snapshot
Cognitive Enhancement in Schizophrenia
inferred← citeshttps://doi.org/10.1016/j.psc.2012.06.010openalex-snapshot
Homelessness in Schizophrenia
inferred← citeshttps://doi.org/10.1016/j.psychres.2007.08.008openalex-snapshot
The economic and social burden of compulsive hoarding
inferred← citeshttps://doi.org/10.1016/j.psychres.2012.09.016openalex-snapshot
The use of the Theory of Planned Behavior to predict engagement in functional behaviors in schizophrenia
inferred← citeshttps://doi.org/10.1016/j.psychres.2013.09.023openalex-snapshot
An ecologically valid performance-based social functioning assessment battery for schizophrenia
inferred← citeshttps://doi.org/10.1016/j.psychres.2015.04.047openalex-snapshot
Prevalence and predictors of medication non-adherence among Chinese patients with first-episode psychosis
inferred← citeshttps://doi.org/10.1016/j.psychres.2015.05.056openalex-snapshot
Sustained reduction in health care costs after adjunctive treatment of graded intensive short-term dynamic psychotherapy in patients with psychotic disorders
inferred← citeshttps://doi.org/10.1016/j.psychres.2016.08.027openalex-snapshot
Validation of the UCSD Performance-based Skills Assessment (UPSA) in Hispanics with and without schizophrenia
inferred← citeshttps://doi.org/10.1016/j.psychres.2017.04.065openalex-snapshot
Computer-assisted cognitive remediation therapy in schizophrenia: Durability of the effects and cost-utility analysis
inferred← citeshttps://doi.org/10.1016/j.rcp.2015.07.002openalex-snapshot
Manejo integral del paciente con esquizofrenia: más allá de los psicofármacos
inferred← citeshttps://doi.org/10.1016/j.schres.2007.11.023openalex-snapshot
Neurocognitive deficits and prefrontal cortical atrophy in patients with schizophrenia
inferred← citeshttps://doi.org/10.1016/j.schres.2008.12.008openalex-snapshot
Physical and mental health-related quality of life among older people with schizophrenia
inferred← citeshttps://doi.org/10.1016/j.schres.2009.03.005openalex-snapshot
Schizophrenia, “just the facts” 4. Clinical features and conceptualization
inferred← citeshttps://doi.org/10.1016/j.schres.2011.10.004openalex-snapshot
Assessment of the effects of AZD3480 on cognitive function in patients with schizophrenia
inferred← citeshttps://doi.org/10.1016/j.schres.2011.11.036openalex-snapshot
The efficacy of supported employment for middle-aged and older people with schizophrenia
inferred← citeshttps://doi.org/10.1016/j.schres.2012.08.013openalex-snapshot
Prospective relationship of duration of untreated psychosis to psychopathology and functional outcome over 12 years
inferred← citeshttps://doi.org/10.1016/j.schres.2012.12.028openalex-snapshot
Initial validation of a computerized version of the UCSD Performance-Based Skills Assessment (C-UPSA) for assessing functioning in schizophrenia
inferred← citeshttps://doi.org/10.1016/j.schres.2013.09.022openalex-snapshot
Identifying youth at risk for psychosis using the Behavior Assessment System for Children, Second Edition
inferred← citeshttps://doi.org/10.1016/j.schres.2015.02.014openalex-snapshot
UPSA-M: Feasibility and initial validity of a mobile application of the UCSD Performance-Based Skills Assessment
inferred← citeshttps://doi.org/10.1016/j.schres.2015.04.031openalex-snapshot
The Management of Schizophrenia in Clinical Practice (MOSAIC) Registry: A focus on patients, caregivers, illness severity, functional status, disease burden and healthcare utilization
inferred← citeshttps://doi.org/10.1016/j.schres.2015.06.022openalex-snapshot
Implications for reactive oxygen species in schizophrenia pathogenesis
inferred← citeshttps://doi.org/10.1016/j.schres.2015.08.017openalex-snapshot
A systematic review and meta-analysis of cognitive remediation in early schizophrenia
inferred← citeshttps://doi.org/10.1016/j.schres.2016.06.022openalex-snapshot
Does cannabidiol have a role in the treatment of schizophrenia?
inferred← citeshttps://doi.org/10.1016/j.schres.2016.07.004openalex-snapshot
Two-stage replication of previous genome-wide association studies of AS3MT-CNNM2-NT5C2 gene cluster region in a large schizophrenia case–control sample from Han Chinese population
inferred← citeshttps://doi.org/10.1016/j.schres.2017.04.050openalex-snapshot
Comparing early signs and basic symptoms as methods for predicting psychotic relapse in clinical practice
inferred← citeshttps://doi.org/10.1016/j.schres.2017.07.001openalex-snapshot
Development and psychometric properties of the Multidimensional Schizotypy Scale: A new measure for assessing positive, negative, and disorganized schizotypy
inferred← citeshttps://doi.org/10.1016/j.schres.2018.07.010openalex-snapshot
Sex differences in DEK expression in the anterior cingulate cortex and its association with dementia severity in schizophrenia
inferred← citeshttps://doi.org/10.1016/j.schres.2019.04.003openalex-snapshot
Feasibility of using a smartphone app to assess early signs, basic symptoms and psychotic symptoms over six months: A preliminary report
inferred← citeshttps://doi.org/10.1016/j.schres.2019.08.011openalex-snapshot
Detecting schizophrenia early: Prediagnosis healthcare utilization characteristics of patients with schizophrenia may aid early detection
inferred← citeshttps://doi.org/10.1016/j.schres.2020.03.036openalex-snapshot
Effects of an extrinsic motivator on the evaluation of cognitive and daily living functions in patients with schizophrenia
inferred← citeshttps://doi.org/10.1016/j.schres.2020.04.019openalex-snapshot
A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis
inferred← citeshttps://doi.org/10.1016/j.schres.2020.06.028openalex-snapshot
A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: Implications for studies of psychosis risk
inferred← citeshttps://doi.org/10.1016/j.schres.2021.01.001openalex-snapshot
Reprint of: A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis
inferred← citeshttps://doi.org/10.1016/j.schres.2021.07.025openalex-snapshot
Effects of IPS plus cognitive remediation in early psychosis: 18-month functioning outcomes of a randomized controlled trial
inferred← citeshttps://doi.org/10.1016/j.tins.2015.06.002openalex-snapshot
Positive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatment
inferred← citeshttps://doi.org/10.1016/j.wneu.2021.06.105openalex-snapshot
Use of Stereoelectroencephalography Beyond Epilepsy: A Systematic Review
inferred← citeshttps://doi.org/10.1016/j.yhbeh.2006.06.027openalex-snapshot
Schizophrenia: A unique translational opportunity in behavioral neuroendocrinology
inferred← citeshttps://doi.org/10.1016/j.yhbeh.2013.02.018openalex-snapshot
The development of psychotic disorders in adolescence: A potential role for hormones
inferred← citeshttps://doi.org/10.1016/s0027-9684(15)30213-3openalex-snapshot
HIV Testing Among Deep South Residents With Serious Psychological Distress
inferred← citeshttps://doi.org/10.1016/s0079-6123(09)17905-0openalex-snapshot
Inducible and conditional transgenic mouse models of schizophrenia
inferred← citeshttps://doi.org/10.1016/s0084-3970(08)70425-0openalex-snapshot
The Economic Burden of Schizophrenia in the United States in 2002
inferred← citeshttps://doi.org/10.1016/s1658-3612(10)70123-2openalex-snapshot
Psychiatric Home Care, Length of Hospital Stay and Risk of Rehospitalization in Patients Suffering from Schizophrenia; A Case Control Study in Al Madinah Al Munawarah Region
inferred← citeshttps://doi.org/10.1017/9781009244503.015openalex-snapshot
Across the Lifespan: Adults and Families
inferred← citeshttps://doi.org/10.1017/9781009244503.018openalex-snapshot
PIER: A Clinical/Epidemiologic System for Prevention of Psychosis
inferred← citeshttps://doi.org/10.1017/9781139839518.012openalex-snapshot
Psychosocial Interventions for Youth Mental Health
inferred← citeshttps://doi.org/10.1017/cbo9781139088077.003openalex-snapshot
General considerations for psychiatric care in the emergency department
inferred← citeshttps://doi.org/10.1017/s0033291716000921openalex-snapshot
Association between actigraphy-derived physical activity and cognitive performance in patients with schizophrenia
inferred← citeshttps://doi.org/10.1017/s0033291717001271openalex-snapshot
Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials
inferred← citeshttps://doi.org/10.1017/s0266462309090059openalex-snapshot
Identifying patient-relevant endpoints among individuals with schizophrenia: An application of patient-centered health technology assessment
inferred← citeshttps://doi.org/10.1017/s0954579412000132openalex-snapshot
The puzzle of schizophrenia: Tracking the core role of cognitive deficits
inferred← citeshttps://doi.org/10.1017/s1041610207005340openalex-snapshot
Self-stigma, self-esteem and age in persons with schizophrenia
inferred← citeshttps://doi.org/10.1017/s1121189x00001172openalex-snapshot
Primary care and the early phases of schizophrenia in the Czech Republic
inferred← citeshttps://doi.org/10.1017/s1355617714000654openalex-snapshot
Commissions and Omissions Are Dissociable Aspects of Everyday Action Impairment in Schizophrenia
inferred← citeshttps://doi.org/10.1021/cn1001123openalex-snapshot
ACS Chemical Neuroscience Molecule Spotlight on Latuda (Lurasidone; SM-13,496)
inferred← citeshttps://doi.org/10.1021/cn2000519openalex-snapshot
Progress toward Positive Allosteric Modulators of the Metabotropic Glutamate Receptor Subtype 5 (mGlu5)
inferred← citeshttps://doi.org/10.1021/cn200108zopenalex-snapshot
ACS Chemical Neuroscience Molecule Spotlight on RG1678
inferred← citeshttps://doi.org/10.1021/cn400023yopenalex-snapshot
Is There a Path Forward for mGlu2 Positive Allosteric Modulators for the Treatment of Schizophrenia?
inferred← citeshttps://doi.org/10.1037/1541-1559.3.3.145openalex-snapshot
Behavioral rehabilitation of the "treatment-refractory" schizophrenia patient: Conceptual foundations, interventions, and outcome data.
showing the first 200 of 566
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.